Patients using tirzepatide show reductions in blood pressure (average 46 mmHg systolic), improved lipid profiles with lower triglycerides, and reduced insulin resistanceall independent of weight loss
Research involving animals indicates that therapeutic levels of glucagon can modulate fat metabolism, energy consumption, and dietary habits
Currently, however, its exact roles in disease development and prevention remain unclear
Some patients report that by varying the dose and missing a couple of days they have experienced better results, due to drug tolerance issues
If GLP-1s are suppressing the release of unwanted dopamine firings, the implications could be immense
May improve cholesterol levels Low-density lipoproteins (LDL) are considered the bad cholesterol and are more likely to cause heart disease and plaques